Clinical Trial Update: SABR for Renal Tumors [NA]

View source ↗

Summary

A clinical trial evaluating stereotactic ablative radiotherapy (SABR) for renal tumors is currently recruiting in Toronto, Canada.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Renal Tumor | NA | Status: RECRUITING